2024 Q2 Form 10-Q Financial Statement
#000109355724000079 Filed on April 25, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
Revenue | $1.004B | $921.0M |
YoY Change | 15.26% | 24.21% |
Cost Of Revenue | $377.6M | $359.1M |
YoY Change | 16.22% | 28.76% |
Gross Profit | $626.7M | $561.9M |
YoY Change | 14.7% | 21.47% |
Gross Profit Margin | 62.4% | 61.01% |
Selling, General & Admin | $332.7M | $319.3M |
YoY Change | 11.91% | 8.38% |
% of Gross Profit | 53.09% | 56.83% |
Research & Development | $136.0M | $141.5M |
YoY Change | 14.0% | 18.91% |
% of Gross Profit | 21.7% | 25.18% |
Depreciation & Amortization | $52.10M | $52.50M |
YoY Change | 19.22% | 26.2% |
% of Gross Profit | 8.31% | 9.34% |
Operating Expenses | $468.7M | $460.8M |
YoY Change | 12.05% | 10.93% |
Operating Profit | $158.0M | $101.1M |
YoY Change | 23.34% | 114.19% |
Interest Expense | $31.40M | $4.600M |
YoY Change | 0.64% | 0.0% |
% of Operating Profit | 19.87% | 4.55% |
Other Income/Expense, Net | $29.80M | $31.40M |
YoY Change | -19.68% | 43.38% |
Pretax Income | $187.8M | $132.5M |
YoY Change | 17.89% | 105.43% |
Income Tax | $44.30M | -$13.90M |
% Of Pretax Income | 23.59% | -10.49% |
Net Earnings | $143.5M | $146.4M |
YoY Change | 23.81% | 201.23% |
Net Earnings / Revenue | 14.29% | 15.9% |
Basic Earnings Per Share | $0.36 | $0.38 |
Diluted Earnings Per Share | $0.35 | $0.36 |
COMMON SHARES | ||
Basic Shares Outstanding | 397.7M shares | 385.5M shares |
Diluted Shares Outstanding | 416.8M shares | 416.7M shares |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $2.969B | $2.621B |
YoY Change | -18.34% | 2.26% |
Cash & Equivalents | $939.2M | $851.2M |
Short-Term Investments | $2.030B | $1.770B |
Other Short-Term Assets | $48.40M | $40.40M |
YoY Change | -74.53% | -6.48% |
Inventory | $570.3M | $589.1M |
Prepaid Expenses | $69.30M | $59.40M |
Receivables | $945.2M | $978.6M |
Other Receivables | $53.50M | $6.200M |
Total Short-Term Assets | $4.848B | $4.621B |
YoY Change | -3.09% | 22.65% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $1.254B | $1.177B |
YoY Change | 8.7% | 9.4% |
Goodwill | $23.30M | $23.20M |
YoY Change | -9.69% | -9.73% |
Intangibles | $114.5M | $123.3M |
YoY Change | -25.75% | -24.63% |
Long-Term Investments | ||
YoY Change | ||
Other Assets | $82.90M | $77.70M |
YoY Change | -82.87% | 37.28% |
Total Long-Term Assets | $1.951B | $1.862B |
YoY Change | 7.32% | 6.46% |
TOTAL ASSETS | ||
Total Short-Term Assets | $4.848B | $4.621B |
Total Long-Term Assets | $1.951B | $1.862B |
Total Assets | $6.799B | $6.482B |
YoY Change | -0.32% | 17.52% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $307.0M | $269.7M |
YoY Change | 14.08% | 1.31% |
Accrued Expenses | $1.400B | $1.296B |
YoY Change | 37.5% | 58.85% |
Deferred Revenue | $14.70M | $16.40M |
YoY Change | 63.33% | 70.83% |
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $1.722B | $1.594B |
YoY Change | -16.79% | -14.52% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $2.496B | $2.494B |
YoY Change | 0.27% | 98.27% |
Other Long-Term Liabilities | $128.1M | $129.4M |
YoY Change | -18.25% | -0.23% |
Total Long-Term Liabilities | $128.1M | $129.4M |
YoY Change | -95.16% | -0.23% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $1.722B | $1.594B |
Total Long-Term Liabilities | $128.1M | $129.4M |
Total Liabilities | $4.365B | $4.235B |
YoY Change | -7.53% | 29.01% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | $1.311B | $1.168B |
YoY Change | 103.49% | 120.96% |
Common Stock | $1.992B | $2.511B |
YoY Change | -12.19% | 8.89% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $2.434B | $2.247B |
YoY Change | ||
Total Liabilities & Shareholders Equity | $6.799B | $6.482B |
YoY Change | -0.32% | 17.52% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $143.5M | $146.4M |
YoY Change | 23.81% | 201.23% |
Depreciation, Depletion And Amortization | $52.10M | $52.50M |
YoY Change | 19.22% | 26.2% |
Cash From Operating Activities | $279.4M | $209.2M |
YoY Change | 46.82% | 34.62% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $66.10M | $56.90M |
YoY Change | 12.03% | -23.83% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$122.8M | -$2.300M |
YoY Change | -75.29% | |
Cash From Investing Activities | -$188.9M | $74.80M |
YoY Change | -66.02% | -140.06% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -1.400M | $4.700M |
YoY Change | -100.15% | -58.04% |
NET CHANGE | ||
Cash From Operating Activities | 279.4M | $209.2M |
Cash From Investing Activities | -188.9M | $74.80M |
Cash From Financing Activities | -1.400M | $4.700M |
Net Change In Cash | 89.10M | $284.9M |
YoY Change | -84.47% | -1599.47% |
FREE CASH FLOW | ||
Cash From Operating Activities | $279.4M | $209.2M |
Capital Expenditures | $66.10M | $56.90M |
Free Cash Flow | $213.3M | $152.3M |
YoY Change | 62.45% | 88.72% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
359100000 | usd |
CY2023Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
278900000 | usd |
CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
561900000 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
462600000 | usd |
CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
141500000 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
119000000.0 | usd |
CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
319300000 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
296400000 | usd |
CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
460800000 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
415400000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
101100000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
47200000 | usd |
CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
31400000 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
17300000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
132500000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
64500000 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-13900000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
15900000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
146400000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
48600000 | usd |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.38 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.13 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
390200000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
386700000 | shares |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.36 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.12 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
416700000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
418500000 | shares |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
146400000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
48600000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-19200000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
1400000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-1400000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
3700000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-20600000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
5100000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
125800000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
53700000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2068600000 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
13400000 | usd |
CY2024Q1 | dxcm |
Stock Issued During Period Value Achievement Of Milestone
StockIssuedDuringPeriodValueAchievementOfMilestone
|
0 | usd |
CY2024Q1 | dxcm |
Stock Issued During Period Value Exercise And Settlement Of Warrants
StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants
|
0 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
39000000.0 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-20600000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2246800000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2131800000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
12300000 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
35200000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
48600000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
5100000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2233000000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
48600000 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
52500000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
41600000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
39000000.0 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
35200000 | usd |
CY2024Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
1900000 | usd |
CY2023Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
1500000 | usd |
CY2024Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-41800000 | usd |
CY2023Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-9300000 | usd |
CY2024Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
7800000 | usd |
CY2023Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
13700000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
5800000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-76600000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
36700000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
59600000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-11400000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
13400000 | usd |
CY2024Q1 | dxcm |
Increase Decreasein Operating Lease Assetsand Liabilities Net
IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
|
2000000.0 | usd |
CY2023Q1 | dxcm |
Increase Decreasein Operating Lease Assetsand Liabilities Net
IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
|
700000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
109600000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
86700000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-60700000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-39300000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
|
3200000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
|
1200000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
209200000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
155400000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
992400000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
809600000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
1121800000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
697600000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
56900000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
74700000 | usd |
CY2024Q1 | us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
-2300000 | usd |
CY2023Q1 | us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
0 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
74800000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-186700000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
13400000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
12300000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
-8700000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
-1100000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4700000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
11200000 | usd |
CY2024Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-3800000 | usd |
CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1100000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
284900000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-19000000.0 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
567500000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
643300000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
852400000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
624300000 | usd |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
851200000 | usd |
CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
623200000 | usd |
CY2024Q1 | us-gaap |
Restricted Cash
RestrictedCash
|
1200000 | usd |
CY2023Q1 | us-gaap |
Restricted Cash
RestrictedCash
|
1100000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
852400000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
624300000 | usd |
CY2024Q1 | us-gaap |
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
|
40700000 | usd |
CY2023Q1 | us-gaap |
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
|
55800000 | usd |
CY2024Q1 | dxcm |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet
|
1100000 | usd |
CY2023Q1 | dxcm |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet
|
1900000 | usd |
CY2024Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
7400000 | usd |
CY2023Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
1000000.0 | usd |
CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div> | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
416700000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
418500000 | shares |
CY2024Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Concentration of Credit Risk</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</span></div> | |
CY2024Q1 | us-gaap |
Unbilled Contracts Receivable
UnbilledContractsReceivable
|
10100000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
7400000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
7400000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
146400000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
48600000 | usd |
CY2024Q1 | us-gaap |
Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
|
2900000 | usd |
CY2023Q1 | us-gaap |
Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
|
1600000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
|
149300000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
|
50200000 | usd |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.38 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.13 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.36 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.12 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
390200000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
386700000 | shares |
CY2024Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
400000 | shares |
CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
8100000 | shares |
CY2022Q1 | dxcm |
Shares Issued In Connection With The Restated Collaboration Agreement
SharesIssuedInConnectionWithTheRestatedCollaborationAgreement
|
2900000 | shares |
CY2024Q1 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
532500000 | usd |
CY2024Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
2045800000 | usd |
CY2024Q1 | us-gaap |
Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
|
18300000 | usd |
CY2024Q1 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
2596600000 | usd |
CY2023Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
315900000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
2157800000 | usd |
CY2023Q4 | us-gaap |
Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
|
15200000 | usd |
CY2023Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
2488900000 | usd |
CY2023Q1 | dxcm |
Fair Value Assets Level3 Transfers Amount
FairValueAssetsLevel3TransfersAmount
|
0 | usd |
CY2024Q1 | dxcm |
Fair Value Assets Level3 Transfers Amount
FairValueAssetsLevel3TransfersAmount
|
0 | usd |
CY2024Q1 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | usd |
CY2023Q1 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | usd |
CY2024Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
2047200000 | usd |
CY2024Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
400000 | usd |
CY2024Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
1800000 | usd |
CY2024Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
2045800000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
2157400000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
1300000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
900000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
2157800000 | usd |
CY2024Q1 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
1770000000 | usd |
CY2024Q1 | us-gaap |
Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
275600000 | usd |
CY2023Q1 | us-gaap |
Debt Instrument Term
DebtInstrumentTerm
|
P12M | |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
2160000000 | usd |
CY2024Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
301200000 | usd |
CY2023Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
319500000 | usd |
CY2024Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
49800000 | usd |
CY2023Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
30000000.0 | usd |
CY2024Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
238100000 | usd |
CY2023Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
210100000 | usd |
CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
589100000 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
559600000 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
59400000 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
58700000 | usd |
CY2024Q1 | dxcm |
Prepaid Inventory Current
PrepaidInventoryCurrent
|
31700000 | usd |
CY2023Q4 | dxcm |
Prepaid Inventory Current
PrepaidInventoryCurrent
|
31500000 | usd |
CY2024Q1 | dxcm |
Deferred Compensation Plan Assets Current
DeferredCompensationPlanAssetsCurrent
|
18300000 | usd |
CY2023Q4 | dxcm |
Deferred Compensation Plan Assets Current
DeferredCompensationPlanAssetsCurrent
|
15200000 | usd |
CY2024Q1 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
6200000 | usd |
CY2023Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
13600000 | usd |
CY2024Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
40400000 | usd |
CY2023Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
49300000 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
156000000.0 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
168300000 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
|
1657600000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
|
1622500000 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
|
549000000.0 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
|
509400000 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
1108600000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
1113100000 | usd |
CY2024Q1 | us-gaap |
Long Term Investments
LongTermInvestments
|
39800000 | usd |
CY2023Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
38500000 | usd |
CY2024Q1 | dxcm |
Long Term Deposits
LongTermDeposits
|
14400000 | usd |
CY2023Q4 | dxcm |
Long Term Deposits
LongTermDeposits
|
14400000 | usd |
CY2024Q1 | dxcm |
Other Long Term Assets
OtherLongTermAssets
|
23500000 | usd |
CY2023Q4 | dxcm |
Other Long Term Assets
OtherLongTermAssets
|
22100000 | usd |
CY2024Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
77700000 | usd |
CY2023Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
75000000.0 | usd |
CY2024Q1 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
269700000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
276400000 | usd |
CY2024Q1 | dxcm |
Accrued Tax Audit And Legal Fees
AccruedTaxAuditAndLegalFees
|
43000000.0 | usd |
CY2023Q4 | dxcm |
Accrued Tax Audit And Legal Fees
AccruedTaxAuditAndLegalFees
|
42600000 | usd |
CY2024Q1 | dxcm |
Pharmacy Rebates
PharmacyRebates
|
1050100000 | usd |
CY2023Q4 | dxcm |
Pharmacy Rebates
PharmacyRebates
|
950700000 | usd |
CY2024Q1 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
7200000 | usd |
CY2023Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
12600000 | usd |
CY2024Q1 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
11900000 | usd |
CY2023Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
7500000 | usd |
CY2024Q1 | us-gaap |
Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
|
18300000 | usd |
CY2023Q4 | us-gaap |
Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
|
15200000 | usd |
CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
46400000 | usd |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
40500000 | usd |
CY2024Q1 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
1446600000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
1345500000 | usd |
CY2024Q1 | dxcm |
Accrued Wages Bonuses And Taxes Current
AccruedWagesBonusesAndTaxesCurrent
|
81300000 | usd |
CY2023Q4 | dxcm |
Accrued Wages Bonuses And Taxes Current
AccruedWagesBonusesAndTaxesCurrent
|
139800000 | usd |
CY2024Q1 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
29200000 | usd |
CY2023Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
31200000 | usd |
CY2024Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
110500000 | usd |
CY2023Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
171000000.0 | usd |
CY2024Q1 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
57600000 | usd |
CY2023Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
58600000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
7400000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
7400000 | usd |
CY2024Q1 | us-gaap |
Asset Retirement Obligation
AssetRetirementObligation
|
15900000 | usd |
CY2023Q4 | us-gaap |
Asset Retirement Obligation
AssetRetirementObligation
|
15700000 | usd |
CY2024Q1 | dxcm |
Other Tax Liabilities Noncurrent
OtherTaxLiabilitiesNoncurrent
|
43700000 | usd |
CY2023Q4 | dxcm |
Other Tax Liabilities Noncurrent
OtherTaxLiabilitiesNoncurrent
|
38700000 | usd |
CY2024Q1 | us-gaap |
Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
|
4800000 | usd |
CY2023Q4 | us-gaap |
Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
|
5200000 | usd |
CY2024Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
129400000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
125600000 | usd |
CY2024Q1 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
36300000 | usd |
CY2023Q1 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
22300000 | usd |
CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
4600000 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
4600000 | usd |
CY2024Q1 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
300000 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
400000 | usd |
CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
31400000 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
17300000 | usd |
CY2024Q1 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
1900000 | usd |
CY2023Q1 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
2200000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
1800000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
1500000 | usd |
CY2024Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
3700000 | usd |
CY2023Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
3700000 | usd |
CY2018Q4 | dxcm |
Number Of Initial Purchasers For Convertible Note Hedge Transactions
NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions
|
2 | purchaser |
CY2024Q1 | us-gaap |
Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
|
192400000 | usd |
CY2024Q1 | dxcm |
Estimated Annual Effective Income Tax Rate Percent
EstimatedAnnualEffectiveIncomeTaxRatePercent
|
0.238 | |
CY2024Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.105 | |
CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
39000000.0 | usd |
CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
35200000 | usd |
CY2024Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | segment |
CY2024Q1 | dxcm |
Number Of Primary Geographic Markets
NumberOfPrimaryGeographicMarkets
|
2 | primarymarket |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
921000000.0 | usd |
CY2024Q1 | dxcm |
Revenue Percentage
RevenuePercentage
|
1 | |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
741500000 | usd |
CY2023Q1 | dxcm |
Revenue Percentage
RevenuePercentage
|
1 | |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
921000000.0 | usd |
CY2024Q1 | dxcm |
Revenue Percentage
RevenuePercentage
|
1 | |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
741500000 | usd |
CY2023Q1 | dxcm |
Revenue Percentage
RevenuePercentage
|
1 | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |